Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion
- PMID: 810575
Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion
Abstract
Ventriculocisternal perfusions with five isotopically labeled drugs were performed in the rhesus monkey and the resultant tissue diffusion concentration profiles in caudate nucleus were analyzed. The periventricular distribution space with respect to perfusate concentration was measured and expressed as microliters per 100 mg wet weight: hydroxyurea = 56; methotrexate = 27; thiotepa = 28; 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) = 64 and cytosine arabinoside greater than 170. The apparent diffusion constants in caudate nucleus were determined for hydroxyurea and methotrexate (2.0 and 1.2 X 10(-6) cm2/sec, respectively); capillary permeability expressed as an extracellular space-transcapillary exchange half-time was estimated to be greater than 2 hours for both compounds. The extracellular fluid-transcapillary half-time was measured for thiotepa and BCNU (1.0 and 0.8 minute, respectively). Cytosine arabinoside continued to be concentrated by periventricular caudate nucleus during the course of perfusion; perfusate clearance measurements suggest a low capillary permeability. The apparent parenchymal diffusion constant and the capillary permeability of a drug in brain are discussed and are considered useful parameters for predicting drug levels after intrathecal administration.
Similar articles
-
Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion.Cancer Treat Rep. 1977 Jul;61(4):625-31. Cancer Treat Rep. 1977. PMID: 406995 No abstract available.
-
Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.Cancer Treat Rep. 1977 Jul;61(4):633-41. Cancer Treat Rep. 1977. PMID: 406996 No abstract available.
-
Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion.Am J Physiol. 1975 Oct;229(4):877-84. doi: 10.1152/ajplegacy.1975.229.4.877. Am J Physiol. 1975. PMID: 1190330
-
Explanation of metrizamide brain penetration: a review.J Comput Assist Tomogr. 1980 Apr;4(2):191-3. doi: 10.1097/00004728-198004000-00011. J Comput Assist Tomogr. 1980. PMID: 6988475 Review.
-
Ventriculocisternal perfusion of calves with vitamin A deficiency.Nutr Rev. 1969 May;27(5):150-2. doi: 10.1111/j.1753-4887.1969.tb05000.x. Nutr Rev. 1969. PMID: 4893714 Review. No abstract available.
Cited by
-
Current pharmacological treatment approaches to central nervous system leukaemia.Drugs. 1991 May;41(5):702-16. doi: 10.2165/00003495-199141050-00003. Drugs. 1991. PMID: 1712705 Review.
-
Leptomeningeal metastases from solid malignancy: a review.J Neurooncol. 2005 Oct;75(1):85-99. doi: 10.1007/s11060-004-8101-x. J Neurooncol. 2005. PMID: 16215819 Review.
-
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.Clin Pharmacokinet. 2002;41(10):691-703. doi: 10.2165/00003088-200241100-00001. Clin Pharmacokinet. 2002. PMID: 12162757 Review.
-
Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015.J Neurooncol. 2003 May;62(3):251-8. doi: 10.1023/a:1023383717833. J Neurooncol. 2003. PMID: 12777076
-
Agile delivery of protein therapeutics to CNS.J Control Release. 2014 Sep 28;190:637-63. doi: 10.1016/j.jconrel.2014.06.017. Epub 2014 Jun 21. J Control Release. 2014. PMID: 24956489 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous